Novozymes delivers historically strong full-year results
26 janv. 2023 02h01 HE
|
Novozymes A/S
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and...
Novozymes confirms upgraded guidance by strong start to Q4
03 nov. 2022 03h00 HE
|
Novozymes A/S
Novozymes delivered 9% organic sales growth in the first nine months of 2022 and 6% organic sales growth in the third quarter. As announced on October 7, the full-year organic sales growth outlook was...
Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
26 avr. 2022 09h14 HE
|
Novozymes A/S
Novozymes delivered solid earnings and double-digit organic sales growth in the first quarter of 2022. Despite negative effects of the tragic war in Ukraine the company increases its full-year organic...
Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
01 févr. 2022 02h01 HE
|
Novozymes A/S
Novozymes is executing on its strategic framework by delivering 6% organic sales growth for 2021 and presenting a solid organic growth outlook of 3-7% for 2022. The company is also on track to meet...
Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance
26 oct. 2021 07h23 HE
|
Novozymes A/S
Novozymes delivered 7% organic sales growth in the third quarter and 6% organic sales growth in the first nine months of 2021. Due to stronger performance the company has upgraded its full-year...
Novozymes is unlocking growth with the ambition of doubling company revenue by 2030
27 sept. 2021 13h19 HE
|
Novozymes A/S
With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with...